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There is accumulating evidence suggesting that children may drive the spread of inﬂuenza epidemics. The
objective of this study was to quantify the lead time by age using laboratory-conﬁrmed cases of inﬂuenza A for
the 1995/1996–2005/2006 seasons from Canadian communities and laboratory-conﬁrmed hospital admissions for
the H1N1/2009 pandemic strain. With alignment of the epidemic curves locally before aggregation of cases, slight
age-speciﬁcdifferences inthe timingofinfectionbecameapparent.Forseasonalinﬂuenza,both the 10–19- and20–
29-year age groups peaked 1 week earlier than other age groups, while during the fall wave of the 2009 pandemic,
infections peaked earlier among only the 10–19-year age group. In the H3N2 seasons, infections occurred an
average of 3.9 (95% conﬁdence interval: 1.7, 6.1) days earlier in the 20–29-year age group than for youth aged
10–19 years, while during the fall pandemic wave, the 10–19-year age group had a statistically signiﬁcant lead of 3
dayscompared with both youngerchildren aged 4–9years andadultsaged 20–29 years (P < 0.0001).This analysis
casts doubt on the hypothesis that younger school-age children actually lead inﬂuenza epidemic waves.
age groups; datainterpretation, statistical; diagnostic techniques andprocedures; disease transmission, infectious;
empirical research; inﬂuenza, human; population surveillance
Abbreviations: CI, conﬁdence interval; SE, standard error.
Studies have shown that children have high clinical attack
rates (1, 2), have high social contact rates within the school
environment (3–5), and play a major role in introducing
inﬂuenza infections into the household (6) and in further
transmission within the household (7). A few studies iden-
tify older school-age students as the group most likely to
drive the local spread (3, 5). Most other studies include
younger school-age children as the drivers of local spread,
with some studies reporting community-wide beneﬁts from
the vaccination of school-age children (8). Viboud et al. (9)
suggest that working-age adults might be responsible for the
spread between communities.
The methods and data to assess the age differences in the
timing of inﬂuenza infections are limited. Excess pneumo-
nia and inﬂuenza admissions and other similar time series,
such as emergency department visits for inﬂuenza-like
illnesses, have been used to identify periods of inﬂuenza
activity. Using these data sources, Brownstein et al. (10)
identify children aged 3–4 years as the age group that was
consistently the earliest, while Sebastian et al. (11) found
little age-speciﬁc difference in the timing of peak activity.
Understanding the relative timing of inﬂuenza infections in
different age groups is of importance to inﬂuenza burden
studies that rely on proxy measures of inﬂuenza activity
(12–14). In Canadian studies of hospital admissions (13,
14), it appeared that the inﬂuenza virus was unlikely to be
responsible for the peaks in respiratory admissions in young
children, as parainﬂuenza virus and respiratory syncytial
virus accounted for a larger proportion of respiratory admis-
sions than did inﬂuenza. In this case, laboratory conﬁrma-
tion would be required to assess the relative timing of
inﬂuenza infections by age group.
The objective of this study was to use our extensive sur-
veillance of laboratory-conﬁrmed inﬂuenza cases over more
109 Am J Epidemiol. 2011;174(1):109–117than 10 seasons to identify the age groups for which inﬂu-
enza activity peaks ﬁrst in the community. The issue of
the effectiveness of school closures during a pandemic is
an important one (15) and one still under consideration
internationally (16). It is hoped that this description of the
age-speciﬁc epidemic curves will also be useful in future
modeling projects addressing this important issue.
MATERIALS AND METHODS
Data sources
Records of conﬁrmed cases of inﬂuenza A from Septem-
ber 1995 to August 2006 were obtained from the FluWatch
program, Public Health Agency of Canada (17, 18). As part
of the national surveillance program, laboratories participat-
ing in the case-by-case program reported detailed epidemi-
ologic information including age, sex, date of specimen
collection, and community of residence for inﬂuenza-
positive specimens. These specimens were submitted to lab-
oratories by clinicians in the course of clinical care and
patient management in inpatient, emergency room or out-
patient settings, and by sentinel physicians participating in
the national inﬂuenza surveillance program. The speciﬁed
community of residence was grouped into census metropol-
itan areas or census agglomerations (19) as appropriate.
Census metropolitan areas and census agglomerations are
groupings of adjacent municipalities and rural areas that are
highly integrated with a central urban area. Census metro-
politan areas have a population of at least 100,000 and an
urban core of at least 50,000 persons, while census agglom-
erations include smaller cities and towns with an urban core
of at least 10,000 persons and a total population under
100,000. As of 2001, there were 33 census metropolitan
areas and 111 census agglomerations in Canada (20).
During the 2009 H1N1 pandemic period, hospital admis-
sions of patients with laboratory conﬁrmation of the pan-
demic strain (A/California/7/2009) were reported to the
Public Health Agency of Canada (18) with 9 of 10 provinces
providing age, date of symptom onset, specimen collection
date or date of hospital admission, and province of admis-
sion throughout the full 2009 pandemic period. Although
the number of laboratory-conﬁrmed cases of seasonal in-
ﬂuenza appears to be temporally representative of the level
of inﬂuenza activity at the community level (21), this was
not the case during the 2009 pandemic, as laboratory testing
practices varied in response to public health needs over
the pandemic period. As a result of the intensive use of
laboratory testing to identify H1N1/2009 infections in
hospitalized patients over the 2009 pandemic period, labo-
ratory-conﬁrmed admissions should provide the best tempo-
rally representative data source available for the fall
pandemic wave and, hence, the use of laboratory-conﬁrmed
hospital admissions as a proxy for the level of inﬂuenza
activity during the pandemic period.
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Figure 1. Laboratory-conﬁrmed cases of inﬂuenza A/100,000 population per season, 1996/1997–2005/2006, by subtype, Canada. The age-
speciﬁc rate of laboratory conﬁrmation of inﬂuenza A virus differs by subtype.
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The epidemic midpoint, deﬁned as the date when cumu-
lative incidence reaches 50% of the cumulative total of the
seasonal cases for 1 season, was determined for each season
and reporting geographic unit (census metropolitan area/
census agglomeration for seasonal inﬂuenza and participat-
ing province for the 2009 pandemic waves). Various inﬂu-
enza A strains routinely cocirculate and, with the exception
of the 2009 pandemic season, strain characterization was
not routine. Hence, seasons were characterized by national
year-end summary reports (18) in order to identify seasons
where a single strain predominated (17, 22). From 1996/
1997 through the 2003/2004 seasons, a single antigenic
strain accounted for at least 80% of the inﬂuenza A speci-
mens characterized. In the 2002/2003 season, while most
H1 specimens were H1N2 rather than H1N1, all inﬂuenza
A(H1) specimens characterized were antigenically similar
to the hemagglutininof thevaccine strain A/New Caledonia/
20/99(H1N1). The neuraminidase of the H1N2 viruses was
closely related to the contemporary H3N2 viruses (22). In-
ﬂuenza A seasons were classiﬁed by subtype and by strain
novelty. The dominant strain was considered novel in 1997/
1998 and 2003/2004, while in other seasons the dominant
antigenic strain had circulated in previous seasons and
the vaccine match was considered good. Most provinces
experienced 2 distinct waves of the H1N1 pandemic
strain: a spring and fall wave. Due to potential differences
in transmission rates during the spring and fall, cases from
the 2 waves were not combined. Pandemic and seasonal
epidemic curves were analyzed separately.
Statistical analysis
After alignment of the epidemic locally, age-speciﬁc
composite epidemic curves were created by aggregation of
cases by the day relative to the local midpoint and age
group. Geographic units with at least 25 cases per season
and seasons where a single inﬂuenza A strain predominated
were included in the analysis. Mean differences in relative
timing and the standard error of the mean were calculated
for each age group and strain category and presented graph-
ically with error bars corresponding to 95% conﬁdence
intervals. Nonoverlapping conﬁdence intervals indicate
a signiﬁcant difference in the timing of infections between
2 agegroups from the same compositeepidemic, although at
a slightly higher level of statistical signiﬁcance. Conﬁdence
intervals for the mean difference between 2 age groups were
calculated on the basis of the standard error of the mean
difference. A regression model approach was used to statis-
tically test for an age effect within a composite epidemic
and to compare the age-speciﬁc timing of 2 epidemics (e.g.,
the spring and fall H1N1/09 waves).
The week of peak activity was noted for each age group,
and the shape of the age-speciﬁc epidemic curves was
shown graphically. As a summary measure of the shape of
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Figure 2. Distribution of laboratory-conﬁrmed inﬂuenza A cases by age and week relative to the community-level epidemic midpoint, Canada,
1996/1997–2005/2006. Age-speciﬁc composite epidemic curves were created by centering the local epidemics relative to their epidemic midpoint
of the geographic unit and aggregating cases for geographic units with at least 25 cases per season and seasons where a single inﬂuenza A strain
predominated.
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minus the ﬁrst quartile or the minimum number of days over
which 50% of the infections occurred) was calculated for
each age group. Presumably, higher within-age-group trans-
mission rates would also be associated with a more intense
activity over a shorter period of time. All analyses were
carried out in SAS Enterprise Guide, Version 4.1, software
(SAS Institute, Inc., Cary, North Carolina).
RESULTS
The number of census metropolitan areas/census agglom-
erations reporting more than 25 laboratory-conﬁrmed inﬂu-
enza A cases to the case-by-case database varied from 10 to
31 communities per season and accounted for 60% of the
conﬁrmed cases. The remaining cases were grouped by
province. The range in timing of peak activity in one season
varied from 8 to 18 weeks across Canada, although asyn-
chronization within a province was minimal (21). The rate
of laboratory-conﬁrmed case reporting for seasonal inﬂu-
enza A virus was highest in the very young and very old,
with pronounced differences by subtype (Figure 1). Slight
differences are noted in the age-speciﬁc composite epidemic
curves for seasonal inﬂuenza (Figure 2). Inﬂuenza A activity
peaked in the same week as the community-wide epidemic
midpoint for most age groups and 1week earlier among
youth aged 10–19 years and young adults aged 20–29 years.
A ﬁner age-group assessment of the average difference in
relative timing indicates that infections occurred approxi-
mately 6 days earlier among youth and young adults com-
pared with persons 75 years of age or older (Figure 3).
On the basis of reported laboratory-conﬁrmed hospital
admissions, the spring wave of the pandemic H1N1/09
strain peaked provincially between early June and mid-July
and nationally in mid-June. The number of hospital admis-
sions continued to decline throughout the summer. The fall
wave peaked provincially between late October and mid-
November and nationally in early November. The vaccine
was authorized by Health Canada on October 21, 2009 (23),
with priority distribution to designated groups starting
shortly thereafter (24). As the composite epidemic curves
for the spring and fall waves (Figure 4) suggest that trans-
mission/epidemic growth was slower during the spring
wave, data from the 2 pandemic waves were not combined.
The proportion of persons aged 10–29 years among all lab-
oratory-conﬁrmed H1N1/09 admissions dropped from 24%
in the spring wave to 18% in the fall wave for an odds ratio
of 0.69 (95% conﬁdence interval (CI): 0.74, 0.97). However,
the average lead time for youth (aged 10–19 years) com-
pared with other age groups combined persisted: 4.6 (95%
CI: 0.7, 8.6) days and 4.7 days (95% CI: 3.7, 5.7) in the
spring and fall waves, respectively. Statistical power for the
spring wave was limited, and lead-time differences for ﬁner
age groups were not statistically signiﬁcant. H1N1/09 activ-
ity during the fall wave peaked 1 week early among youth
10–19 years of age than among other age groups (Figure 5).
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Figure 3. Differences in the timing of inﬂuenza A epidemic waves by age group among laboratory-conﬁrmed cases, Canada, 1996/1997–2003/
2004. After alignment of the epidemic locally, age-speciﬁc composite epidemic curves were created by aggregating cases by the day relative to the
local midpoint and age group. The mean differences in relative timing and the standard error of the mean were calculated for each age group. Error
bars correspond to 95% conﬁdence intervals.
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ilar for the fall wave of the H1N1/09 strain and the 2 H3N2
seasons where a new antigenic strain emerged quickly
and the vaccine was also poorly matched (in the 1997/
1998 season, the A/Sydney/05/97 H3N2 strain replaced
the A/Wuhan/359/95 strain, and A/Fujian/411/02 replaced
the previous H3N2 strain, A/Panama/2007/99, in the 2003/
2004 season) (Figure 6A). The relative timing of infections
was not statistically different for the 6 younger age groups
(covering the ages of 0–64 years). The gap between the 2
curves is accounted for by a shift of approximately 2 days in
the overall epidemic midpoint resulting from a shift in dis-
ease burden toward younger age groups during the pan-
demic. The delay in timing between youth aged 10–19
years and persons aged 65 years or older was signiﬁcantly
reduced from 6.2 (95% CI: 5.3, 7.2) days to 3.4 (95% CI:
2.7, 4.1) days for the novel H3N2 seasons and H1N1/09
pandemic, respectively. In the remaining H3N2 seasons
where there was some exposure to the antigenic strain in
the previous season and the vaccine was well matched to the
dominant strain, infections occurred earliest in the 20–29-
year age group (Figure 6B). The 2 seasons when the H1
antigenic strain A/New Caledonia/20/99 was the dominant
inﬂuenza A strain showed the strongest lead time in the 10–
19-year age group (Figure 6C).
Despite slight differences in the age-speciﬁc timing of
infections, the shapes of the age-speciﬁc epidemic curves
appeared to be similar (Figures 2 and 5). The interquartile
range for the age-speciﬁc epidemic waves ranged from 11 to
14daysforthesecondH1N1/09pandemicwaveandfrom20
to 25 days for seasonal inﬂuenza A/H3N2. In both cases, the
minimal interquartile range corresponded to the 10–19-year
age group, suggesting that this age group has the most in-
tense within-class transmission.
In additional subanalyses of seasonal inﬂuenza by sex,
geography, and season, the 15–19-year age group was the
age group most often associated with the earliest infections
and shortest interquartile range, observations which are sug-
gestive of higher within-group transmission rates for this
age group. Lead-time differences for the 15–19-year age
groups were statistically signiﬁcant when compared with
age groups other than the 10–14-year and 20–29-year age
groups. Of note, the age proﬁles for urban (census metro-
politan areas) compared with rural areas (the rest of the
province as a geographic unit) and for males compared
with females were similar. In some years (typically milder
inﬂuenza seasons), the age group differences were not
statistically signiﬁcant.
DISCUSSION
After alignment of epidemics at the provincial or com-
munity level, small differences in the age-speciﬁc timing of
inﬂuenza infections have been identiﬁed. During the fall
pandemic wave, infections peaked noticeably earlier among
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Figure 4. Distribution of laboratory-conﬁrmed inﬂuenza A cases/admissions, by week relative to the local epidemic midpoint, Canada, 2009.
Composite epidemic curves are shown for both waves of the H1N1/09 pandemic strain in Canada and for seasonal inﬂuenza epidemic waves. As
the composite epidemic curves for the spring and fall waves suggest that transmission/epidemic growth was slower during the spring wave, data
from the 2 pandemic waves were analyzed separately.
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(95% CI: 1.6, 4.0; standard error (SE): 0.6)-day lead in the
timing of infections compared with younger children aged
4–9 years and an average 3.0 (95% CI: 1.6, 4.3; SE: 0.7)-day
lead compared with young adults aged 20–29 years. The age
pattern of the fall wave of the 2009 pandemic was fairly
similar to the pattern observed in the 2 H3N2 seasons with
a novel antigenic strain (A/Sydney/05/97 in the 1997/1998
season and A/Fujian/411/02 in 2003/2004), as illustrated in
Figure 6A. In contrast, for the H3N2 seasons where the
antigenic strain was not novel and the vaccine well matched,
infections among young adults aged 20–29 years led infec-
tions among youth aged 10–19 years by 3.9 (95% CI: 1.7,
6.1; SE: 1.1) days. The largest observed difference of 8.6
(95% CI: 6.3, 10.9; SE: 1.2) days was between young adults
aged 20–29 years and children 4–9 years of age (Figure 6B).
The age-speciﬁc differences were usually within 1 week for
most age groups. For the 2 H1 seasons, a longer delay
among adults aged 45 years or older of approximately 2–3
weeks compared with youth aged 10–19 years was noted.
This may have been due to the cocirculation of 2 distinct but
antigenically similar strains during the 2002/2003 season.
Although the hemagglutinin samples of the H1N2 strains
were antigenically similar to that of the vaccine strain A/
New Caledonia/20/99 (H1N1), the level of cross-protection
between the H1N1 and H1N2 strains may have been less
than for other antigenically similar strains. It is possible that
the level of activity for these 2 strains peaked at different
times with differential clinical attack rates by age.
Our results are in agreement with those of the study of
social contacts by Glass and Glass (3), where high school
students and young adults were identiﬁed as the age group
most likely to form the transmission backbone for the next
pandemic because of the nature of their contact networks.
Our results tend not to support the inclusion of younger
school-age children (5–9 years) in the lead group as others
have suggested (4, 10) despite their high attack rate (25).
The relative timing for children aged 10–13 years appears to
be intermediate relative to older and younger age groups.
Variability in the timing of peak inﬂuenza activity by age
was noted in an earlier study by Monto et al. (26) on the
basis of inﬂuenza-like illness consultation rates, virus iso-
lation, and serology in a single community. The results of
studies assessing age-speciﬁc differences in the timing of
peak inﬂuenza-like illness consultation rates, emergency
room visits, or pneumonia and inﬂuenza admissions are
mixed (1, 10, 11). Although statistical methods exist to es-
timate a seasonal baseline for time series that are not spe-
ciﬁc to inﬂuenza, such as pneumonia and inﬂuenza
admissions, and attribute the excess to inﬂuenza or other
respiratory virus (13, 27, 28), these statistical estimates
do not have the precision of methods using laboratory-
conﬁrmed cases. With less statistical power, inﬂuenza-like
illness-based studies would be less likely to ﬁnd age-speciﬁc
differences. Although it is reasonable to assume that the
peak in adult pneumonia and inﬂuenza admissions corre-
sponds to the peak in inﬂuenza activity, this is not the case
for children, where parainﬂuenza virus and respiratory
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Figure 5. Distribution of laboratory-conﬁrmed pandemicinﬂuenza hospitaladmissions, by age and week relative to the community-level epidemic
midpoint, H1N1/09/fall wave, Canada, 2009. The 10–19-year age group leads the H1N1/09 fall pandemic wave.
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Figure 6. Age-group differences in the timing of inﬂuenza A waves, Canada, 1997–1998 and 2003–2004 seasons. A, the age structure of the fall
wave of the H1N1/09 pandemic compared with H3N2 seasons where the predominant strain emerged quickly and the vaccine was not a good
antigenic match to the predominant circulating strain. The relative timing of infections was not statistically different for the 6 younger age groups
(coveringthe agesof 0–64years).Thegap betweenthe2 curvesisaccounted for byashift of approximately 2 daysinthe overallepidemicmidpoint
resulting from a shift in disease burden toward younger age groups during the pandemic. B, the age structure for the fall wave of the H1N1/09
pandemic compared with seasonal H3N2 waves for seasons where the antigenic strain circulated in the previous season and the vaccine was
considered a good antigenic match to the predominant circulating strain. C, the age structure for seasonal inﬂuenza by subtype and vaccine match.
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than inﬂuenza and where peaks in respiratory admissions
did not correspond to peaks in inﬂuenza activity (13, 14).
The higher transmission rate observed during the fall pan-
demic wave compared with the spring wave (inferred
from differences in the epidemic growth rate) (Figure 4)
was expected and is consistent with the seasonal trend in
transmission rates that was observed for seasonal inﬂuenza
(21).
The 1-week difference in the timing ofinfections between
youth and older adults is very short compared with differ-
ences in the timing of peak activity across Canada, which
has been observed to be as long as 13 weeks (21). The age-
speciﬁc differences are slight, and as laboratory conﬁrma-
tion is not considered geographically representative, it was
essential to control for these geographic differences in
order to identify the age-speciﬁc differences. The date of
symptom onset was available for most of the hospital
admissions with pandemic H1N1/09; however, laboratory-
conﬁrmed cases for seasonal inﬂuenza were identiﬁed only
by the date of specimen collection. Thus, we were unable to
account for any age-speciﬁc differences in the time from
symptom onset to presentation for medical care and speci-
men collection in the analysis of the seasonal inﬂuenza data.
Persons presenting for medical care because of complica-
tions more than a week after onset of symptoms are, how-
ever, likely to have already cleared the virus, and positive
ﬁndings are expected to be less likely at that time (29). The
average delay from symptom onset to hospital admission
with laboratory-conﬁrmed H1N1/09 was 3.7 (95% CI: 3.2,
4.1) days, increasing with increasing age from 2.7 to 4.7
days. Based on a very small proportion of cases of seasonal
inﬂuenza in 2007/2008, the average delay from symptom
onset to specimen procurement was 3 (95% CI: 2.8, 3.2)
days, although the age trend was reversed. Although we
used 2 different proxies for the level of inﬂuenza activity
(laboratory-conﬁrmed admissions and laboratory-conﬁrmed
cases representing a mix of inpatient and outpatients), the
results appear to be in good agreement, and the generaliza-
tion of age-speciﬁc differences in the relative timing of
laboratory-conﬁrmed admissions to the relative timing of
infection appears reasonable. The potential impact of the
various study limitations is likely in days rather than weeks
and less than the observed variation from season to season.
Each season is different, and although we compared the age-
speciﬁc differences in the timing of infections by strain sub-
type and vaccine match/previous circulation of the antigenic
strain, the number of seasons included in this study was
too small to fully assess possible reasons for the observed
differences in the age structure of the epidemic curves.
During the pandemic period, clinical and laboratory test-
ing procedures varied in response to public health and clin-
ical needs and laboratory capacity, so that detection rates
were not constant over the pandemic period. The initial
objective was to document the ﬁrst 100 cases of the pan-
demic strain, as our ability to assess the virulence of the
pandemic strain was otherwise limited. As many of the early
cases that were identiﬁed among recent travelers to Mexico
were relatively mild, intense surveillance continued beyond
the ﬁrst 100 cases before becoming more restrictive. Hence,
the number of laboratory-conﬁrmed hospital admissions
was used, rather than the number of laboratory-conﬁrmed
cases, to describe the epidemic curve for the pandemic
period. The roll out of the vaccination campaign as the
epidemic peakedin November in manyjurisdictions appears
to have had a limited impact on the study results. Infants
under the age of 6 months were not vaccinated, and persons
over the age of 65 years were not among the priority groups
that received the vaccine during the period of peak activity
(24). Although priority was given to all children aged from 6
months to 5 years because of their higher risk for severe
outcomes, this was not the lead age group, and calculations
(not shown) based on estimates of weekly vaccination rates
suggest that the direct effects of thevaccination effort would
have minimal effect on the average timeliness of inﬂuenza
infections by age.
Many studies have identiﬁed schoolchildren as the drivers
of the local spread of inﬂuenza, prompting considerations of
inﬂuenza vaccination for all schoolchildren and the use of
school closures to mitigate the effects of a pandemic (15, 25,
30–34). Not all studies agree on the likely beneﬁtsof closing
schools (35, 36), and our study of the timing of laboratory-
conﬁrmed cases of inﬂuenza A suggests that the effect of
age on timing may be smaller than predicted by various
models (31, 35, 37). Mitigation of inﬂuenza epidemics re-
mains complex, although the role of youth and young adults
as potential drivers of the epidemic waves of seasonal and
pandemic inﬂuenza should also be considered. Although
this study casts doubt on the hypothesis that younger
school-age children lead inﬂuenza epidemic waves, inter-
ventionstargetingyoungchildrenmaystillhaveasigniﬁcant
impact on the size of the epidemic. Even though the age-
speciﬁc lead times are short, these differences in timing are
sufﬁcient to bias age-speciﬁc relative risks calculated early
in the course of an epidemic or pandemic wave.
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